Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
29 nov. 2024 08h05 HE
|
Silo Pharma, Inc.
Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the...
Psychemedics Corporation Launches New Ketamine Hair Testing Service
29 août 2024 09h00 HE
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing, announces the launch of its new ketamine hair testing solution.
U.S. Ketamine Clinics Market Report 2024-2030: Depression, Anxiety, PTSD, On-site Therapy, Online Therapy Size, Share, & Trends Analysis
16 août 2024 07h54 HE
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "U.S. Ketamine Clinics Market Size, Share, & Trends Analysis Report By Treatment (Depression, Anxiety, PTSD, Others), By Therapy (On-site Therapy,...
Ketamine (CAS 6740-88-1) Global Market Research Report 2024: Market Trends, Developments, Key Players, and Primary Downstream Sectors
22 avr. 2024 10h03 HE
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Ketamine (CAS 6740-88-1) Global Market Research Report 2024" report has been added to ResearchAndMarkets.com's offering. This global report offers...
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
16 avr. 2024 08h00 HE
|
PharmaTher Holdings Ltd.
TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its...
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
27 févr. 2024 07h58 HE
|
Clearmind Medicine Inc.
New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE:...
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
27 févr. 2024 07h58 HE
|
SciSparc Ltd
TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
Beckley Academy Welcomes New Faculty for 2024 Psychedelic Therapy Practitioners Courses
14 déc. 2023 09h00 HE
|
Beckley Academy
Beckley Academy Welcomes New Faculty for 2024 Psychedelic Therapy Practitioners Courses
Beckley Waves Acquires Nue Life
26 oct. 2023 09h00 HE
|
Beckley Waves
Beckley Waves Acquires Nue Life
Addition of Ketamine Assisted Therapy Provider to the Beckley Waves Portfolio Strengthens its Network of Psychedelic Care
Silo Pharma to Present at Psychedelic Drug Development Conference
24 avr. 2023 08h15 HE
|
Silo Pharma, Inc.
ENGLEWOOD CLIFFS, NJ, April 24, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional...